Can Early Ischemic Lesion Recurrence on Diffusion-Weighted MRI Affect Functional Outcome after Acute Ischemic Stroke?

다국어 초록 (Multilingual Abstract)

Background and Purpose Ischemic lesion recurrence on diffusion-weighted imaging (DWI-LR) is a frequently observed phenomenon after acute ischemic stroke. However, no study has elucidated the impact of DWI-LR on functional outcome.
Methods Among a consecutive series of patients who presented with focal symptoms or signs compatible with stroke within 48 hours from the onset over a 50-month period, those who had relevant ischemic lesions on initial DWI and underwent follow-up DWI within 14 days after the onset were enrolled in this study. As outcome variables, the scores on the modified Rankin Disability Scale (mRDS) at 3 months and 1 year were measured prospectively and dichotomized into good (0-2) vs. poor (3-6). When calculating odds ratios (ORs), adjustment was performed for age, previous stroke, initial score on the NIH Stroke Scale, stroke subtype, and IV thrombolysis.
Results Among those 786 patients finally enrolled in this study, 221 (28.1%) had DWI-LR. For a poor outcome at 3 months, the crude ORs of any, symptomatic, and asymptomatic DWI-LR were 2.70 [95% confidence interval (CI), 1.96 to 3.72], 10.03 (95% CI, 4.39 to 22.96), and 2.04(95% CI, 1.44 to 2.88), respectively. With adjustment, the OR of symptomatic DWI-LR was 6.44(95% CI, 2.50 to 16.57), whereas those of any and asymptomatic DWI-LR lost their statistical significance: 1.44 (95% CI, 0.94 to 2.20) and 1.04 (95% CI, 0.65 to 1.65), respectively. Analyzing with the 1-year outcome produced similar results.
Conclusions This study shows that symptomatic early lesion recurrence can affect functional outcome after acute ischemic stroke, whereas an asymptomatic one may not.

참고문헌 (Reference)

1 Sulter G, "Use of the Barthel index and modified Rankin scale in acute stroke trials" 30 : 1538-1541, 1999

2 Pugsley W, "The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning" 25 : 1393-1399, 1994

3 "The International Stroke Trial(IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group" 349 : 1569-1581, 1997

4 Hardie K, "Tenyear risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study" 35 : 731-735, 2004

5 Petty GW, "Survival and recurrence after first cerebral infarction:a population-based study in Rochester,Minnesota,1975 through 1989" 50 : 208-216, 1998

6 Prentice RL, "Surrogate endpoints in clinical trials:definition and operational criteria" 8 : 431-440, 1989

7 Kang DW, "Silent ischemic lesion recurrence on magnetic resonance imaging predicts subsequent clinical vascular events" 63 : 1730-1733, 2006

8 Coutts SB, "Silent ischemia in minor stroke and TIA patients identified on MR imaging" 65 : 513-517, 2005

9 Moroney JT, "Risk factors for early recurrence after ischemic stroke:the role of stroke syndrome and subtype" 29 : 2118-2124, 1998

10 Olivot JM, "Relationships between infarct growth,clinical outcome,and early recanalization in diffusion and perfusion imaging for understanding stroke evolution(DEFUSE)" 39 : 2257-2263, 2008

11 Weimar C, "Predicting functional outcome and survival after acute ischemic stroke" 249 : 888-895, 2002

12 Banks JL, "Outcomes validity and reliability of the modified Rankin scale:implications for stroke clinical trials:a literature review and synthesis" 38 : 1091-1096, 2007

13 Berge E, "Low molecularweight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:a double-blind randomised study.HAEST Study Group.Heparin in Acute Embolic Stroke Trial" 355 : 1205-1210, 2000

14 "Low molecular weight heparinoid,ORG 10172(danaparoid),and outcome after acute ischemic stroke:a randomized controlled trial.The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment(TOAST)Investigators" 279 : 1265-1272, 1998

15 Merino JG, "Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders" 38 : 2919-2923, 2007

16 Longstreth WT Jr, "Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people:the Cardiovascular Health Study" 55 : 1217-1225, 1998

17 van Swieten JC, "Interobserver agreement for the assessment of handicap in stroke patients" 19 : 604-607, 1988

18 Lee BC, "International experience in stroke registries: Korean Stroke Registry" 31 (31): S243-S245, 2006

19 Longstreth WT Jr, "Incidence,manifestations,and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly:the Cardiovascular Health Study" 33 : 2376-2382, 2002

20 Sacco RL, "Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack:a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke:co-sponsored by the Council on Cardiovascular Radiology and Intervention:the American Academy of Neurology affirms the value of this guideline" 37 : 577-617, 2006

21 Lansberg MG, "Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging" 58 : 613-617, 2001

22 European Stroke Initiative recommendations for stroke management, "European Stroke Council,European Neurological Society and European Federation of Neurological Societies" 10 : 335-351, 2000

23 Toyoda K, "Early recurrence of ischemic stroke in Japanese patients:the Japan standard stroke registry study" 24 : 289-295, 2007

24 Kwan J, "Early neurological deterioration in acute stroke:clinical characteristics and impact on outcome" 99 : 625-633, 2006

25 Kang DW, "Early ischemic lesion recurrence within a week after acute ischemic stroke" 54 : 66-74, 2003

26 Kang DW, "Early and late recurrence of ischemic lesion on MRI:evidence for a prolonged stroke-prone state?" 63 : 2261-2265, 2004

27 Derdeyn CP, "Diffusion-weighted imaging as a surrogate marker for stroke as a complication of cerebrovascular procedures and devices" 22 : 1234-1235, 2001

28 Sacco RL, "Determinants of early recurrence of cerebral infarction.The Stroke Data Bank" 20 : 983-989, 1989

29 Adams HP Jr, "Classification of subtype of acute ischemic stroke.Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment" 24 : 35-41, 1993

30 Fearn SJ, "Cerebral injury during cardiopulmonary bypass:emboli impair memory" 121 : 1150-1160, 2001

31 Sylaja PN, "Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients" 68 : 415-419, 2007